Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Sarah Seiler"'
Autor:
Kyrill S Rogacev, Gunnar H Heine, Günther Silbernagel, Marcus E Kleber, Sarah Seiler, Insa Emrich, Simone Lennartz, Christian Werner, Adam M Zawada, Danilo Fliser, Michael Böhm, Winfried März, Hubert Scharnagl, Ulrich Laufs
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146920 (2016)
BACKGROUND:Impaired renal function causes dyslipidemia that contributes to elevated cardiovascular risk in patients with chronic kidney disease (CKD). The proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of the LDL receptor and pl
Externí odkaz:
https://doaj.org/article/8dcb668c1ea8478eb82d0291afb96536
Autor:
Thierry Hannedouche, Giovanni Tripepi, Olga Balafa, Aikaterini Papagianni, Carmine Zoccali, Radovan Hojs, Claudia Torino, Rosa Sicari, Luna Gargani, Itzchak Slotki, Linda Shavit, Alberto Martínez-Castelao, Alexandre Seidowsky, Francesca Mallamaci, Krzysztof Letachowicz, Enrico Fiaccadori, Dimitrie Siriopol, Yuri Battaglia, Ziad A. Massy, Patrick Rossignol, Gérard M. London, Friedo W. Dekker, Kostas C. Siamopoulos, Pantelis Sarafidis, Robert Ekart, Thomas Bachelet, Kitty J. Jager, Adrian Covic, Giuseppe Regolisti, Marie-Jeanne Coudert-Krier, Aristeidis Stavroulopoulos, Andrzej Wiecek, Sarah Seiler-Mußler, Fabio Lizzi, Rocco Tripepi, Danilo Fliser, Carolina Polo-Torcal, Marian Klinger, Agata Miskiewicz, Eugenio Picano
Publikováno v:
Kidney international, 100(6), 1325-1333. Nature Publishing Group
Lung congestion is a risk factor for all-cause and cardiovascular mortality in patients on chronic hemodialysis, and its estimation by ultrasound may be useful to guide ultrafiltration and drug therapy in this population. In an international, multi-c
Autor:
Gunnar H. Heine, Danilo Fliser, Insa E. Emrich, Alexander B. Sellier, Michael Böhm, Adam M. Zawada, Sarah Seiler-Mußler
Publikováno v:
American Journal of Nephrology. 52:808-816
Introduction: High plasma fibroblast growth factor 23 (FGF-23) predicts cardiovascular events in chronic kidney disease (CKD) patients. Experimental evidence suggests FGF receptor 4 (FGFR4) activation by FGF-23, and deficiency of the soluble form of
Autor:
Radovan Hojs, Claudia Torino, Eugenio Picano, Krzysztof Letachowicz, Sarah Seiler-Mußler, Fabio Lizzi, Giovanni Tripepi, Itzchak Slotki, Pantelis Sarafidis, Robert Ekart, Ziad A. Massy, Charalampos Loutradis, Alexandre Seidowsky, Rocco Tripepi, Dimitrie Siriopol, Marian Klinger, Patrick Rossignol, Enrico Fiaccadori, Danilo Fliser, Luna Gargani, Gérard M. London, Kostas C. Siamopoulos, Yuri Battaglia, Andrzej Wiecek, Nejra Prohic, Linda Shavit, Carmine Zoccali, Francesca Mallamaci, Thierry Hannedouche, Olga Balafa, Aristeidis Stavroulopoulos, Rosa Sicari, Thomas Bachelet, Marie-Jeanne Coudert-Krier, Adrian Covic, Giuseppe Regolisti, Alberto Martínez-Castelao
Publikováno v:
Journal of Nephrology. 33:583-590
Introduction Since infammation alters vascular permeability, including vascular permeability in the lung, we hypothesized that it can be an amplifer of lung congestion in a category of patients at high risk for pulmonary oedema like end stage kidney
Autor:
Ulrich Laufs, Sven Meyer, Paul Christian Schulze, Hans-F. Schött, Gunnar H. Heine, Sarah Seiler-Mußler, Bruno Scheller, Adam M. Zawada, Oliver Weingärtner, Anja Kerksiek, Dieter Lütjohann, Ursula Ulbricht, Arne Fuhrmann, Danilo Fliser, Bodo Cremers, Silvia Friedrichs, Michael Böhm
Publikováno v:
Atherosclerosis. 279:17-22
Background and aims There are safety issues regarding plant sterol ester-enriched functional food. Oxidized plant sterols, also called oxyphytosterols, are supposed to contribute to plant sterol atherogenicity. This study aimed to analyze association
Autor:
Farah Al Sabie, Justine Bacchetta, Vincent Brandenburg, Ming Chang Hu, Chang Huei Chen, Lingfeng Chen, Erica L. Clinkenbeard, Michael J. Econs, Daniela Egli-Spichtig, Reinhold G. Erben, Sarah Erem, Carlos C. Faraco, Seiji Fukumoto, Regina Goetz, Alexander Grabner, Dieter Haffner, Mark R. Hanudel, Ping He, Gunnar H. Heine, Martin Hewison, Jan-Luuk Hillebrands, Keith A. Hruska, Chou-Long Huang, Erik A. Imel, Anna Jovanovich, Stefanie Krick, Makoto Kuro-o, Seong Min Lee, Maren Leifheit-Nestler, Rik Mencke, Orson W. Moe, Moosa Mohammadi, John Musgrove, Javier A. Neyra, Hannes Olauson, Katherine Wesseling Perry, Farzana Perwad, J. Wesley Pike, Mohammed S. Razzaque, Beatrice Richter, Isidro B. Salusky, Renal Section, Sarah Seiler-Mußler, Taylor Struemph, Marc G. Vervloet, Curtis Vrabec, Matthew J. Williams, Clinton B. Wright, Allen Zinkle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40c13d3f4e067b721f26d0665211b969
https://doi.org/10.1016/b978-0-12-818036-5.01002-8
https://doi.org/10.1016/b978-0-12-818036-5.01002-8
Publikováno v:
Fibroblast Growth Factor 23 ISBN: 9780128180365
FGF23 measurements have entered clinical medicine several years ago, and FGF23 has become a treatment target in endocrinology with the introduction of burosumab in 2018. A detailed understanding of FGF23 is needed to properly differentiate various ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b313a03d28e6664ecc519a913f3ee909
https://doi.org/10.1016/b978-0-12-818036-5.00005-7
https://doi.org/10.1016/b978-0-12-818036-5.00005-7
Autor:
Sarah Seiler-Mußler
Publikováno v:
Dialyse aktuell. 25:262-263
Die Verschreibung von direkten oralen Antikoagulanzien (DOAK) zur Prävention thromboembolischer Ereignisse nimmt bei Vorhofflimmern (VHF) und dialysepflichtiger Nierenerkrankung trotz fehlender harter Evidenz aus klinischen Studien zu Effektivität,
Autor:
Christian Ukena, Gunnar H. Heine, Sarah Seiler-Mussler, Dominic Kaddu-Mulindwa, Insa E. Emrich, R. D’Amelio, Stefan Wagenpfeil, Vincent Brandenburg, Danilo Fliser, Fabio Lizzi, Michael Böhm, J. D. Siegel
Publikováno v:
BMC Medicine
BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
Background In patients with iron deficiency anemia, ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) allow high-dose iron repletion. While FCM is reported to induce hypophosphatemia, the frequency of hypophosphatemia after an equivalent dos
Autor:
Linda Feuer, Gunnar H. Heine, Jean-Marie Launay, Insa E. Emrich, Nicolas Vodovar, Kathrin Untersteller, Danilo Fliser, Hélène Nougué, Sarah Seiler-Mussler
Publikováno v:
Nephrology Dialysis Transplantation. 34:100-108
Background Since the introduction of sacubitril/valsartan in clinical cardiology, neprilysin has become a major target for heart failure treatment. Plasma neprilysin concentration has been discussed as a novel biomarker that predicts cardiac events.